SAKARTA is an exciting start-up with an objective to transform the Regenerative Medicine field through the delivery of automated systems that reduce both production bosts and product variability, thus enabling cell and gene therapies to become a mainstream component of an advanced healthcare system.
Regenerative medicine offers a transformative approach to healthcare, with the potential to not only treat, but cure disease. The therapeutic application of cells, or cell-based therapy, forms a fundamental part of this landscape and already has global revenues of over US$1 billion.